BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 33312335)

  • 1. RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs.
    Nunomura A; Perry G
    Oxid Med Cell Longev; 2020; 2020():2638130. PubMed ID: 33312335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review of miRNA as Biomarkers in Alzheimer's Disease.
    Swarbrick S; Wragg N; Ghosh S; Stolzing A
    Mol Neurobiol; 2019 Sep; 56(9):6156-6167. PubMed ID: 30734227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer's disease.
    Chen J; Qi Y; Liu CF; Lu JM; Shi J; Shi Y
    J Gene Med; 2018 Jun; 20(6):e3014. PubMed ID: 29543360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease.
    Wong HK; Veremeyko T; Patel N; Lemere CA; Walsh DM; Esau C; Vanderburg C; Krichevsky AM
    Hum Mol Genet; 2013 Aug; 22(15):3077-92. PubMed ID: 23585551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3.
    Shioya M; Obayashi S; Tabunoki H; Arima K; Saito Y; Ishida T; Satoh J
    Neuropathol Appl Neurobiol; 2010 Jun; 36(4):320-30. PubMed ID: 20202123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of microRNAs associated with Alzheimer's disease using oxidative stress cell model and different strains of senescence accelerated mice.
    Zhang R; Zhang Q; Niu J; Lu K; Xie B; Cui D; Xu S
    J Neurol Sci; 2014 Mar; 338(1-2):57-64. PubMed ID: 24423585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.
    Arena A; Iyer AM; Milenkovic I; Kovacs GG; Ferrer I; Perluigi M; Aronica E
    Curr Alzheimer Res; 2017; 14(12):1305-1317. PubMed ID: 28720071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular network of microRNA targets in Alzheimer's disease brains.
    Satoh J
    Exp Neurol; 2012 Jun; 235(2):436-46. PubMed ID: 21945006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain.
    Lukiw WJ; Alexandrov PN
    Mol Neurobiol; 2012 Aug; 46(1):11-9. PubMed ID: 22302353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrovascular miRNAs Track Early Development of Alzheimer's Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation.
    Chum PP; Bishara MA; Solis SR; Behringer EJ
    J Alzheimers Dis; 2024; 99(s2):S187-S234. PubMed ID: 37458037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide profiling and predicted significance of post-mortem brain microRNA in Alzheimer's disease.
    Henriques AD; Machado-Silva W; Leite REP; Suemoto CK; Leite KRM; Srougi M; Pereira AC; Jacob-Filho W; Nóbrega OT;
    Mech Ageing Dev; 2020 Oct; 191():111352. PubMed ID: 32920076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulated Pro-inflammatory MicroRNAs (miRNAs) in Alzheimer's disease (AD) and Age-Related Macular Degeneration (AMD).
    Pogue AI; Lukiw WJ
    Cell Mol Neurobiol; 2018 Jul; 38(5):1021-1031. PubMed ID: 29302837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of microRNAs in understanding sex-based differences in Alzheimer's disease.
    Llera-Oyola J; Carceller H; Andreu Z; Hidalgo MR; Soler-Sáez I; Gordillo F; Gómez-Cabañes B; Roson B; de la Iglesia-Vayá M; Mancuso R; Guerini FR; Mizokami A; García-García F
    Biol Sex Differ; 2024 Jan; 15(1):13. PubMed ID: 38297404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression analysis of adult-onset Drosophila Alzheimer's disease model.
    Kong Y; Wu J; Yuan L
    Curr Alzheimer Res; 2014; 11(9):882-91. PubMed ID: 25274109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling microRNA from Brain by Microarray in a Transgenic Mouse Model of Alzheimer's Disease.
    Wang LL; Min L; Guo QD; Zhang JX; Jiang HL; Shao S; Xing JG; Yin LL; Liu JH; Liu R; Guo SL
    Biomed Res Int; 2017; 2017():8030369. PubMed ID: 29057267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid.
    Müller M; Kuiperij HB; Claassen JA; Küsters B; Verbeek MM
    Neurobiol Aging; 2014 Jan; 35(1):152-8. PubMed ID: 23962497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of microRNA-34a in Alzheimer's disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity.
    Sarkar S; Jun S; Rellick S; Quintana DD; Cavendish JZ; Simpkins JW
    Brain Res; 2016 Sep; 1646():139-151. PubMed ID: 27235866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
    Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNAs in Alzheimer Disease - A Therapeutic Perspective.
    Gupta P; Bhattacharjee S; Sharma AR; Sharma G; Lee SS; Chakraborty C
    Curr Alzheimer Res; 2017; 14(11):1198-1206. PubMed ID: 28847283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-146a Dysregulates Energy Metabolism During Neuroinflammation.
    Kim SJ; Russell AE; Wang W; Gemoets DE; Sarkar SN; Simpkins JW; Brown CM
    J Neuroimmune Pharmacol; 2022 Jun; 17(1-2):228-241. PubMed ID: 34028667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.